title: Widespread use of Xpert(®) MTB/RIF will most probably reduce the total number of TB cases notified.
authors.affiliation: International Union Against Tuberculosis and Lung Disease, Paris, France. atrebucq@theunion.org.
authors.forename: Arnaud
authors.initials: A
authors.lastname: Trébucq
authors.affiliation: National Institute for Research In Tuberculosis, Chennai, India.
authors.forename: Santha
authors.initials: S
authors.lastname: Devi
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage*; D003140:Communicable Disease Control / Q000458:organization & administration*; D018563:Disease Notification / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D008297:Male; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis*
chemical_list: D000995:Antitubercular Agents